Are you still getting a lot of unwanted calls?
On my landline, yes, I still have one, I’m still getting unwanted calls. However, not as many as in the […]
Prescription Drugs
New guidelines for preventing strokes includes specific risks for women
Updated guidelines for healthcare professionals to use as prevention strategies for people with no history of strokes includes new discoveries
Corporate price gouging and inflation: Kamala Harris gets it
About a dozen times I’ve written about price gouging being one of the biggest drivers of inflation, along lamenting about
Money tips for 2024
Every week, I write and send out my newsletter Helpful Money Tips for You. This week’s newsletter has a number of financial tips that will be valuable to to you and your family during 2024. See it below. I’m getting a lot of compliments on the newsletter. People like it because it’s brief and has information from a variety of sources that they can put to use right away.
Beware: Ozempic and the other new weight-loss drugs have problems
The medical community and consumers are excited about the new injectable weight-loss drugs, such as Ozempic and Wegovy. The drugs suppress appetite and slow digestion. Celebrities, including Orpha Winfrey, are taking the drugs. Most doctors and health care providers like to have a pill or shot that will fix patients’ problems.
Top consumer and personal finance stories of 2023
It’s that time of year again. It’s unbelievable that 2023 has rolled by so fast. That means that the 2024 election is getting even closer and closer, an election with so many consequences for consumers and their financial lives. As usual, I’m one of the few reporters writing about the top consumer and personal finance stories of the year, research that I enjoy.
At last: Biden administration takes action on prescription drug price gouging
About 50 percent or more of price increases driving recent inflation is caused from price gouging. On Thursday, finally, President Biden called out the pharmaceutical industry for raising prices too much. Dozens of pharmaceutical companies will be required to pay rebates to Medicare for outrageous price hikes on prescription drugs.
Inflation eases, despite corporate price gouging
It’s amazing that as we’re all suffering from inflation so little is said about corporate price gouging and the role it’s playing in price increases. Fortunately, there’s a watchdog group that keeps researching inflation. Here’s the latest from Accountable.US: The increase in basic prices having risen at the smallest rate since September 2021.
Full approval of lecanemab to treat Alzheimer’s by the FDA fails patients and the public, consumer group says
The approval of a new drug to treat Alzheimer’s disease is controversial. The U.S. Food and Drug Administration gave full approval to the drug lecanemab (Leqembi) Thursday to treat adults with Alzheimer’s disease. In January, Public Citizen, a consumer advocacy organization, urged the agency not to approve the drug.